Printer Friendly
The Free Library
17,740,679 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

It's official: Medicare covers Avonex. (news).




Good news for anyone on Medicare who is considering or already taking Avonex: as of August 1, 2002, Medicare covers this FDA-approved MS disease-modifying drug because it is administered via intramuscular injection Noun 1. intramuscular injection - an injection into a muscle
injection, shot - the act of putting a liquid into the body by means of a syringe; "the nurse gave him a flu shot"
. However, Medicare will cover Avonex only when it is given "incidental Contingent upon or pertaining to something that is more important; that which is necessary, appertaining to, or depending upon another known as the principal.

Under Workers' Compensation statutes, a risk is deemed incidental to employment when it is related to whatever a
 to a physician's services"--that is, in a doctor's office or hospital outpatient setting. Medicare will not cover Betaseron, Copaxone, and Rebif under any circumstances, because they are administered via subcutaneous injection Noun 1. subcutaneous injection - an injection under the skin
injection, shot - the act of putting a liquid into the body by means of a syringe; "the nurse gave him a flu shot"
.

Because the decision regarding Avonex is new, you should contact your local Medicare program to make sure Avonex is included on its list of covered drugs, or formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions.

National Formulary  see under N.


for·mu·lar·y
n.
. Local contact information can be found by calling 800-MEDICARE (800-633-4227) or by visiting www.medicare.gov/ coverage/home.asp and selecting your state and "prescription drugs prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, ".

While we welcome this relief for Avonex users, the National MS Society believes it is unacceptable and inappropriate for Medicare to cover only one of the four FDA-approved disease-modifying injected drugs. The Society's national advocacy office is working with other concerned groups to make the case that Medicare must cover all four disease-modifying MS drugs.
COPYRIGHT 2002 National Multiple Sclerosis Society
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Inside MS
Article Type:Brief Article
Geographic Code:1USA
Date:Oct 1, 2002
Words:184
Previous Article:Kids to parents! (Cover Story).
Next Article:INCOMIN results favor frequent interferon dosage. (news).(Independent Comparison of Interferon )(Brief Article)
Topics:



Related Articles
FRA approves Avonex for relapsing form of MS. (multiple sclerosis)(includes related information)
Conference call helps answer Axonex questions.
Neutralizing antibodies - and what they mean. (in multiple sclerosis care)
Rebif and Avonex go head-to-head.(in Serono Laboratories clinical trial)
Avonex for people who might get MS?(multiple sclerosis)
Serono seeks FDA approval for Rebif. (News).(Brief Article)
Heads up! Has your health plan cut back on MS drug coverage? (National MS Society News).(multiple sclerosis)
FDA approves Rebif. (News).(Brief Article)(Product Announcement)
Rebif [in context].
INCOMIN results favor frequent interferon dosage. (news).(Independent Comparison of Interferon )(Brief Article)

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles